5 Biotech and Pharma Stocks with FDA Catalysts this December

5 Biotech and Pharma Stocks with FDA Catalysts this December

By Arpita Dutt 2017 has been a pretty good year for pharma and biotech stocks where FDA decisions are concerned. The regulatory body has approved 40 novel drugs so far in 2017, easily surpassing last year’s total tally of 22. There were quite a few landmark approvals...

Pin It on Pinterest